Study: Low-intensity warfarin has post-THA benefits

05/17/2013 | Healio

Treating patients with low-intensity warfarin for six weeks before total hip arthroplasty was associated with low incidence of bleeding and symptomatic venous thromboembolism in the next three months, according to a study in the journal Thrombosis Research. "Low-intensity warfarin should be considered in future studies to identify the regimen that optimally balances risk of bleeding and symptomatic venous thromboembolism in a real world setting," the authors concluded.

View Full Article in:

Healio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA